National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research : [transcript of the third meeting], February 14-15, 1975 ... Bethesda, Maryland.

  • United States. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research
Date:
[1975]
Catalogue details

Licence: Public Domain Mark

Credit: National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research : [transcript of the third meeting], February 14-15, 1975 ... Bethesda, Maryland. Source: Wellcome Collection.

    13/566 (page 5)
    qu ~ 9 10 1] un en Guidelines should be concerned with existing problems and those that might reasonably be unticipated to arise in the future. Human experimentation “‘s a necessary part of medical research because certain informetion can be obtained in no. other way. Such experimentation may be attended by a certain element of risk; therefore, in reseazch design, all available means must be employed to ensure safety and to narrow the risk. This includes fuil exploretion of appropri- Personnel shall not be required to participate in perinatal research which is opposed to their ethical atti- tudes. It is recognized that the welfare of the patients are always the primary concern. Clinical management should not be affected by research objectives, regardless oi the persons -- whether clinician, researcher, or both -- who make decisions and recommendations to the patients. A physician's involvement in 4 research protocol:in no way diminishes his responsibility to or sensitivity for the most appropriate clinical management of the patient. For example, decision for abortion or affect its timing, such as delay abortion to obtain a later gestational age which might be more suitable for the research project. _ ee a ee) eer, ee nen ee a SOE = OS A GT A TS LT ET NS LS oe A TS TT nan ;